Soft data produces mixed results

Twenty four hours of weak economic news around the globe puts Asia Pacific investors in two minds today. Further weakening in China and Europe could bring on stimulus efforts, and weakness in the US defers Fed tightening. However, an ongoing sell off in global bond markets suggests investors are looking through the worse than forecast numbers and taking a bad news is bad news approach.

Twenty four hours of weak economic news around the globe puts Asia Pacific investors in two minds today. Further weakening in China and Europe could bring on stimulus efforts, and weakness in the US defers Fed tightening. However, an ongoing sell off in global bond markets suggests investors are looking through the worse than forecast numbers and taking a bad news is bad news approach.

A day of digestion in Australia may see recently elevated volumes investors comb through the details of a softer global outlook and the Federal budget. A lower opening may be a harbinger of further sentiment decline, as the market tempers yesterday’s enthusiasm for budget stimulus for small business with the realpolitik of passing a hostile Senate.

A weaker USD on the back of lower than expected US retail sales sees the AUD trading above 81 US cents.  This effectively kicks international support for local share to the sidelines – another cause for concern. Two of the four big banks are now ex-dividend, and NAB will attain the same status tomorrow, adding further weight to concerns above dividend yield related positions in the face of a bond market rout.

For further comment from Michael McCarthy at CMC Markets please call 02 8221 2135.

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles